Biotech investors are always looking for companies developing new therapies for tough-to-treat diseases like cancer, but that growth focus almost always puts them at odds with dividend investors, who are more interested in steady and stable growth.

Finding biotech investments that fit the needs of both growth and dividend investors is no easy job. But there are three intriguing companies with ties to biotech that do pay dividends. In the following slide showshow, you'll learn how Amgen (NASDAQ:AMGN), PDL Biopharma (NASDAQ:PDLI), and Teva Pharmaceuticals (NYSE:TEVA) are leveraging biologics for dividend-friendly cash flow. 

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.


Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have The Motley Fool recommends Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Compare Brokers